| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $51.8M | +49.6% |
| SG&A Expense | $17.1M | +3.1% |
| Operating Income | -$68.9M | -34.5% |
| Net Income | -$64.5M | -71.1% |
| EPS (Basic) | -$6.18 | -500.0% |
| EPS (Diluted) | -$6.18 | -500.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $86.9M | +127.2% |
| Current Assets | $88.9M | +113.1% |
| Total Assets | $94.9M | +96.2% |
| Current Liabilities | $12.4M | +75.1% |
| Total Liabilities | $16.5M | +33.0% |
| Stockholders' Equity | $78.4M | +118.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.1M | -13.5% |
| Investing Cash Flow | -$267K | +53.6% |
| Financing Cash Flow | $101.0M | — |